Three active forms of aspartic proteinase from Mason-Pfizer monkey virus

Virology

Volumn 245, Issue 2, 1998, Pages 250-256

  Zábranský, Aleš ^a   Andreánsky, Martin ^b   Hrušková Heidingsfeldová, Olga ^a   Havlíček, Vladimír ^c   Hunter, Eric ^b   Ruml, Tomáš ^d   Pichová, Iva ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^c University of Alabama at Birmingham   (United States)

^d INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; MASON PFIZER MONKEY VIRUS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEQUENCE ANALYSIS;

MACACA MULATTA; MASON-PFIZER MONKEY VIRUS; MONKEY VIRUS; PAPAYA MOSAIC VIRUS; RNA VIRUSES;

EID: 0344863185     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9173     Document Type: Article

References (33)

1. Pol. J. Virol. 70:1996;7228-7232.
2. Arad G., Bar-Meir R., Almong N., Chorev M., Shtorch A., Kotler M. Avian sarcoma leukemia virus proteinase linked to the adjacent Gag polyprotein is enzymatically active. Virology. 214:1995;439-444.
3. Bradac J., Hunter E. Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of thegag. Virology. 138:1984;260-275.
4. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Burstein H., Bizub D., Kotler M., Schatz G., Vogt V. M., Skalka A. M. Processing of avian retroviral Gag polyprotein precursors is blocked by a mutation in the NC-PR cleavage site. J. Virol. 66:1992;1781-1785.
6. Daniel M. D., King N. W., Letwin N. L., Hunt R. D., Sehgal P. K., Desroisiers R. C. A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science. 223:1984;602-605.
7. Elder J. H., Lerner D. L., Hasselkus-Light C. S., Fontenot D. J., Hunter E., Luciw P. A., Montelaro R. C., Philips T. R. Distinct subset of retroviruses encode dUTPase. J. Virol. 66:1992;1791-1794.
8. Fine D. L., Landon J. C., Pienta R. J., Kubicek M. T., Valerio M. J., Loeb W. F., Chopra H. C. Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J. Natl. Cancer Inst. 54:1975;651-658.
9. Fine D., Schochetman G. Type D primate retroviruses: A review. Cancer Res. 38:1978;3123-3139.
10. Hrušková-Heidingsfeldová O., Andreansky M., Fábry M., Bláha I., Strop P., Hunter E. Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase. J. Biol. Chem. 25:1995;15053-15058.
11. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:1994;71-83.
12. Chopra H. C., Mason M. M. A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Res. 30:1970;2081-2086.
13. Kaplan A. H., Swanstrom R. HIV-1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA. 88:1991;4528-4532.
14. Konvalinka J., Litterst M. A., Welker R., Kottler H., Rippman F., Heuser A.-M., Kräusslich H.-G. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69:1995;7180-7186.
15. Kotler M., Arad G., Hughes S. H. Human immunodeficiency virus type 1 Gag-proteinase fusion proteins are enzymatically active. J. Virol. 66:1992;6781-6783.
16. Laco G. S., Fitzgerald M. C., Morris G. M., Olson A. J., Kent S. B., Elder J. E. Molecular analysis of the feline immunodeficiency virus protease: Generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases. J. Virol. 71:1997;5505-5511.
17. Marx P. A., Maul D. H., Osborn K. G., Lerche N. W., Moody P., Lovenstine L. J., Henrickson R. V., Arthur L. O., Gilden R. V., Gravell M., London W. T., Sever J. L., Levy J. A., Munn R. J., Gardner M. Simian AIDS: Isolation of a D-type retrovirus and transmission of the diseases. Science. 223:1984;1083-1086.
18. Oertle S., Spahr P.-F. Role of the Gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA. J. Virol. 64:1990;5757-5763.
19. Pichová I., Štrop P., Sedláček J., Kaprálek F., Benes V., Trávníček M., Pavlíčková L., Souček M., Kostka V., Foundling S. Isolation and biochemical characterization of the p15Gag proteinase of myeloblastosis associated virus expressed inE. coli. Int. J. Biochem. 24:1992;235-242.
20. Precigoux G., Geoffre S., Leonard R., Llido S., Dautant A., Langlois d'Estaintot B., Picard P., Menard A., Guillemain B., Hospital M. Modelling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids. FEBS Lett. 326:1993;237-240.
21. Rhee S. S., Hunter E. Structural role of the matrix protein of type D retrovirus in Gag polyprotein stability and capsid assembly. J. Virol. 64:1990;4383-4389.
22. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
23. Schatz G., Pichova I., Vogt V. M. Analysis of cleavage site mutation between the NC and PR Gag domains of Rous sarcoma virus. J. Virol. 71:1997;444-450.
24. Shoeman R. L., Höner B., Stoller T. J., Kesselmeier C., Miedel C. M., Traub P., Graves M. C. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin and gliar fibrillary acidic protein. Proc. Natl. Acad. Sci. USA. 87:1990;6336-6340.
25. Snášel J., Pichová I. The cleavage of host cell proteins by HIV-1 protease. Folia Biol. Prague. 42:1996;227-230.
26. Sommerfelt M. A., Petteway S. R. Jr., Dreyer G. B., Hunter E. Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J. Virol. 66:1992;4220-4227.
27. Sonigo P., Barker Ch., Hunter E., Wain-Hobson S. Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus. Cell. 45:1986;375-385.
28. Stewart L., Vogt V. M. Proteolytic cleavage at the Gag-Pol junction in avian leukosis viruses: Differences in vitro and in vivo. Virology. 204:1994;45-59.
29. Stromberg K., Benveniste R. E., Arthur L. O., Rabin H., Giddens W. E., Ochs H. E., Morton W. R., Tsai C. C. Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis. Science. 224:1984;289-292.
30. Tomasselli A. G., Howe W. J., Sawyer T. K., Wlodawer A., Heinrikson R. L. The complexities of AIDS: An assessment of HIV protease as a therapeutic target. Chim. Oggi-Chem. Today. 1991;6-26.
31. Wlodawer A., Erickson J. W. Structure based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:1993;543-548.
32. Zybarath G., Carter C. Domain upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-pol influence PR autoprocessing. J. Virol. 69:1995;3878-3884.
33. Zybarath G., Kräusslich H.-G., Partin K., Carter C. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68:1994;240-250.